4th ACE DRUG DISCOVERY SUMMIT

2nd - 3rd April, 2025

WEDNESDAY-THURSDAY

Leonardo Hotel London, UK

About 4th ADDS

4th ACE Drug Discovery Summit, 2025 provides a platform for scientists, researchers and decision makers from all over the world to debate on the latest scientific advances, trends, current challenges and futuristic advancements in Drug Discovery. The two day conference is designed to maximize collaborations and innovation with pharma and technology presentations, interactive sessions by professionals from industry and academia. The Summit features talks on the cutting edge of the discipline that include latest scientific advancements in the areas of drug discovery, AI, screening automation, high content imaging, disease modelling, cell and gene therapy and more. Summit will be attracting senior strategic decision-makers with top-level speakers, interactive round-tables, knowledge-sharing panel sessions, in-depth workshops and superb networking. Join us at 4th ACE Drug Discovery, 2025 to meet scientists from around the world and to learn how to move pharma from the bench to the market. We look forward to your contribution!

Why Attend

ADDS Thought Leaders

Soroush Safaei

Senior Principal Scientist
 | Sanofi

Michael Hennig

CEO |
 leadXpro

JOHN NIELAND

CSO |
2N Pharma

ADELE ROWLEY

Chief Scientific Officer |
Mironid

Mark Eccleston

CEO |
VALIRX PLC

SHAYONI DUTTA 

Senior Principal Data
Scientist | GSK

Maria Groves

Senior Director |
AstraZeneca

NORMAN MILLER

Cofounder and CSO |
Kutanios Ltd

Floriana Cremasco

Senior Scientist | Roche Glycart AG

Alejandra Tomas

Head of Section of Cell Biology and Functional Genomics | Imperial College London

Jens Smiatek

Digital Lead@DEV NCE | Boehringer Ingelheim Pharma GmbH & Co. KG

ASIF AHMED

Executive Chairman & CEO | MirZyme Therapeutics

SHAYONI DUTTA 

Senior principal Data
scientist | GSK

SONA CHANDRA 

President, AI
Pangea Bio

BRENDAN SWAIN

CSO
Shift Bioscience Ltd

ELIOTT HARFOUCHE

Partner | Nodes Advisors AG


CHRYSI SERGAKI

Microbiome Group Leader | Medicines and Healthcare products Regulatory Agency

BENIN JOSEPH

Director Discovery |
Pentagrit

ADELE ROWLEY

Chief Scientific Officer |
Mironid

Attendees
0 +
Speakers
0 +
Companies
0 +
Networking Hours
0 +

Solutions at ADDS

🔷 Antibody Engineering
🔷 ADMUPI (Toxicology)
🔷 Covering Biological studies
🔷 Discovery Outsourcing Services
🔷 Drug Discovery Technology Platforms
🔷 High Throughput Screening
🔷 Licensing
🔷 ln licensing/out licensing discovery                   projects proprietary technologies
🔷 PK/PD
🔷 Protein identification Services
🔷 Screening and Profiling Services
🔷 Transgenisis Services

🔷 Biochemistry
🔷 Biomarker Validation
🔷 Data Management Technology
🔷 DNA & RNA Analysis
🔷 Gene Expression Profiling Solutions
🔷 Lead Generation
🔷 lmaging/biomarker service/collaboration
🔷 Medicinal Chemistry
🔷 Pharmacogenetic Testing
🔷 Preclinical
🔷 Research & Development
🔷 Structural Biology

🔷 Bio-informatics
🔷 Combinatorial Chemistry
🔷 Digital lmaging Technology
🔷 DNA Sequencing Services
🔷 Genomics
🔷 Lead Optimatisation and Profiling, HTS             Technology
🔷 Molecular Biology
🔷 Pharmacology
🔷 Principal Scientists
🔷 Reagents Technology
🔷 Target identification & Validation

Who Will Attend

🔷 CEO
🔷 Director of Discovery Strategy Portfolio
🔷 Head of DMPK
🔷 Head of R&D Licensing
🔷 Senior Director Discovery Research
🔷 VP of Chemistry
🔷 VP Translational Medicine

🔷 CSO
🔷 Director of Screening & Compound Profiling
🔷 Head of Drug Design
🔷 Head Pharmacology & Toxicology
🔷 Senior Director Function Genomics
🔷 Head Pharmacology & Toxicology

🔷 Director Discovery Alliances
🔷 Executive Director Chemistry
🔷 Head of Molecular Toxicology
🔷 Principal Scientist
🔷 VP & Director of Drug Discovery
🔷 VP Target Discovery & Assessment

Attendee Breakdown

Attendee Demographics

Agenda

🔷 08:45 – 09:00 Chairman’s Welcome Remarks

🔷 09:00 – 09:30 Presentation no.1:

The rise of deep learning in drug discovery:

  • The recent applications of deep learning in drug discovery research
  • Deep learning methods/tools relevant to research.
  • Future development of deep learning in drug discovery

Buyers 2025 Pharma / Biotech

To view this protected content, enter the password below:

if you dont have password. Contact us at [email protected]

Our Sponsors

10x_GENOMICS_LOGO
parse-bio-white-logo

Our Partners

Media Partners

Venue - Leonardo Hotel London, UK

Leonardo Hotel London, UK is the ideal venue for your next conference. The hotel features modern, fully-equipped conference rooms designed to accommodate various event sizes and formats, from intimate meetings to large seminars. Each conference room is outfitted with the latest audiovisual technology, free high-speed Wi-Fi, and comfortable seating arrangements to ensure a productive and seamless experience. Attendees can take advantage of the hotel’s excellent catering services, providing a range of delicious dining options tailored to your event’s needs. Guests will appreciate the stylish, comfortable accommodations, complete with amenities such as soundproof windows, air conditioning, and flat-screen TVs. Situated in the heart of London, the hotel offers easy access to public transport and local attractions, enhancing the overall experience for attendees. With a dedicated events team ready to assist with every detail, Leonardo Hotel London ensures a successful and memorable conference experience.

SPONSORSHIP OPPORTUNITIES

If you wish to inquire about sponsorship prospects, kindly reach out to:

Taha Bilal

Head of Sales

     : [email protected]

SPEAKER / DELEGATE OPPORTUNITIES

If you wish to inquire about speaking opportunities, and to book attendee pass, kindly reach out to:

Huma Taha

Head of Marketing

     : [email protected]

     : +44 020 7173 5735